Samarendra Mohanty

Samarendra Mohanty is currently serving as the Chief Scientific Officer at Nanoscope Therapeutics Inc. since June 2021. Previously, Samarendra held the same position at NanoScope Technologies, LLC since January 2016. Samarendra's responsibilities include leading efforts for clinical translation of technologies developed in NanoScope laboratory for early cancer detection, vision restoration in RP/AMD patients, and development of technologies for pain and cancer control. Samarendra Mohanty holds a Ph.D. from the Indian Institute of Science (IISc) and an M.Tech from the Indian Institute of Technology, Delhi.